Clinical Trials in Los Angeles

Showing 8901-8920 of 14,465 trials

SVRII Family Factors Study

NCT01582529

The purpose of this study is to learn about the relationship between family factors and developmental and psychosocial outcomes in children with congenital heart disease at 6 years of age. A secondary purpose is to learn more about psychosocial outcomes in children with congenital heart disease and their families over time. About 250 mothers and fathers at 15 medical centers will take part in this study; 35 will be from Children's Hospital of Wisconsin.

Hypoplastic Left Heart Syndrome

Medical College of Wisconsin187 participantsStarted Jun 2012

Los Angeles, California, United States • Wilmington, Delaware, United States • St. Petersburg, Florida, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)

NCT01327846

Main Study (CACZ885M2301): The purpose of the pivotal phase of this trial was to test the hypothesis that canakinumab treatment of patients with myocardial infarction (MI) at least one month prior to study entry and elevated hsCRP could prevent recurrent cardiovascular events. The purpose of the extension phase of the main study is to collect additional long-term safety data on continued exposure to canakinumab in patients who participated in the pivotal phase. Sub-study 1 (CACZ885M2301S1): The purpose of this sub-study was to evaluate the effect of quarterly subcutaneous canakinumab treatment for 24 months comparted with placebo on the carotid plaque burden measured by integrated vascular MRI in patients enrolled in the CACZ885M2301 study (CANTOS). Sub-study 2 (CACZ885M2301S2): The purpose of this CANTOS sub-study was to determine whether, in patients with type 2 diabetes participating in the CANTOS main study, canakinumab compared to placebo, on top of standard of care could increase insulin secretion and insulin sensitivity.

Atherosclerosis

Novartis Pharmaceuticals10,066 participantsStarted Apr 2011

Athens, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +1128 more locations

SVRII Family Factors Study

Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)

Find Trials by Condition in Los Angeles

Lubiprostone for Children With Constipation

Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis

Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo

Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy

Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome

Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone

Genomics Used to Improve DEpression Decisions

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain

Farber Disease Natural History Study

Rosuvastatin Interethnic PK Study

Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults